Search Within

Gilles Andre Salles

Formats
  1. Meeting Abstract (181)
  2. Journal Article (77)
  3. Research Letter (18)
  4. Review (17)
  5. Editorial (5)
  6. Correspondence (3)
  7. Conference Paper (2)
  8. Guidelines (2)
  9. Book Section (1)
Groups
  1. Department of Medicine (306)
  2. Hematologic Malignancies, Division of (306)
  3. Center for Hematologic Malignancies (166)
  4. Lymphoma (162)
  5. Survivorship Research (117)
  6. Graduate Medical Education (109)

More Groups

People
  1. Maria Palomba (111)
  2. Andrew Zelenetz (75)
  3. Lorenzo Falchi (65)
  4. Anita Kumar (64)
  5. Gunjan Shah (63)
  6. Miguel-Angel Perales (60)

More People

Years
  1. 2025 (23)
  2. 2024 (67)
  3. 2023 (97)
  4. 2022 (69)
  5. 2021 (44)
  6. 2020 (6)
Publications
  1. Blood (127)
  2. Hematological Oncology (28)
  3. Journal of Clinical Oncology (18)
  4. Blood Advances (16)
  5. Haematologica (14)
  6. British Journal of Haematology (9)

More Publications

Publishers
  1. American Society of Hematology (144)
  2. Wiley Blackwell (30)
  3. Elsevier Inc. (20)
  4. American Society of Clinical Oncology (18)
  5. Ferrata Storti Foundation (14)
  6. Nature Publishing Group (14)

More Publishers

Results (306)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Outcomes of T-cell/histiocyte-rich large B-cell lymphoma treated with higher-intensity therapy in the rituximab era: Insights from a retrospective analysis
    Journal Article

    Luttwak, E.; Robin, E. T.; Drill, E.; Boardman, A.; Caron, P.; Epstein-Peterson, Z.; Falchi, L.; Ghione, P.; Hamlin, P. A.; Horwitz, S. M.; more...
    Leukemia and Lymphoma (2025)

    Fulltext@MSK | Save
  • T-ICAHT: Grading and prognostic impact of thrombocytopenia after CAR T-cell therapy
    Journal Article

    Rejeski, K.; Sanz, J.; Fei, T.; Nair, M. S.; Hashmi, H.; Avigdor, A.; Beyar-Katz, O.; Bücklein, V. L.; Curran, K. J.; Einarsdottir, S.; more...
    Blood (2025)

    Fulltext@MSK | Save
  • Results from first-in-human phase I study of a novel CD19-1XX chimeric antigen receptor with calibrated signaling in Large B-cell lymphoma
    Journal Article

    Park, J. H.; Palomba, M. L.; Perica, K.; Devlin, S. M.; Shah, G.; Dahi, P. B.; Lin, R. J.; Salles, G.; Scordo, M.; Nath, K.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Leveraging immunologically based therapies to treat diffuse large B-cell lymphoma
    Review

    Lue, J. K.; Healton, S. E.; Salles, G. A.
    Trends in Cancer (2025)

    Fulltext@MSK | Save
  • Outcomes of CD19 CAR-T therapy in central nervous system lymphoma: Insights from a multicentre experience
    Journal Article

    Cassanello, G.; Luttwak, E.; Brown, S.; Devlin, S. M.; Imber, B.; Ip, A.; Leslie, L. A.; Accav, N. G.; Avigdor, A.; Marcus, R.; more...
    British Journal of Haematology (2025)

    Fulltext@MSK | Save
  • Humoral vaccine responses following Chimeric Antigen Receptor T-cell therapy for hematological malignancies
    Journal Article

    Einarsdottir, S.; Lobaugh, S.; Luan, D.; Gomez-Llobell, M.; Subramanian, P.; Devlin, S.; Chung, D.; Dahi, P. B.; Falchi, L.; Giralt, S.; more...
    Blood Cancer Journal (2025)

    Fulltext@MSK | Save
  • Analysis of peripheral neuropathy in the POLARIX study using clinician- and patient-reported outcomes
    Research Letter

    Trněný, M.; Fogliatto, L.; Gardner, F.; Flinn, I.; Larouche, J. F.; Haioun, C.; Canales, M.; Goto, H.; Hajek, R.; Salles, G.; more...
    Blood Advances (2025)

    Fulltext@MSK | Save
  • Non-relapse mortality with bispecific antibodies: A systematic review and meta-analysis in lymphoma and multiple myeloma
    Review

    Tix, T.; Alhomoud, M.; Shouval, R.; Iacoboni, G.; Cliff, E. R. S.; Hansen, D. K.; Usmani, S. Z.; Salles, G.; Perales, M. A.; Cordas dos Santos, D. M.; more...
    Molecular Therapy (2025)

    Fulltext@MSK | Save
  • Barriers to chimeric antigen receptor T-cell therapy
    Research Letter

    Valtis, Y. K.; Chin, K. K.; Nemirovsky, D.; Devlin, S. M.; Yisraeli Salman, M.; Boussi, L.; Cadzin, B.; McLoughlin, C.; Cathcart, E.; Davis, P.; more...
    JAMA Oncology (2025)

    Fulltext@MSK | Save
  • Predictors of outcomes with covalent BTK inhibitor treatment in relapsed/refractory TP53-mutant mantle cell lymphoma
    Research Letter

    Uppal, M.; Joseph, A.; Drill, E.; Hamlin, P.; Falchi, L.; Noy, A.; Owens, C.; Epstein-Peterson, Z. D.; Salles, G.; Zelenetz, A. D.; more...
    British Journal of Haematology (2025)

    Fulltext@MSK | Save